Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX 77030, USA.
Lab Chip. 2016 Aug 7;16(15):2955-62. doi: 10.1039/c6lc00561f. Epub 2016 Jul 11.
Here we developed an integrated volumetric bar-chart chip (IV-Chip) technology by integration of our previous V-Chip with a fluid handling design to generate an instrument-free POC device and greatly reduce the detection time and effort. The IV-Chip test requires only 1 μL of serum separated from finger-prick blood. The serum sample and ELISA reagents are directly loaded into the device using a pipette, and a shift of the two layers of the device generates homogeneous liquid segments in the microfluidic channel. Under vacuum pressure generated by a regular syringe, the segments flow into the ELISA wells in sequence and a sandwich ELISA reaction takes place. As a result of the automated washing and reacting strategy, the IV-Chip allows rapid tests for myocardial infarction biomarkers, and turnaround time is greatly reduced to 15 min. The specificity and accuracy of quantitative multiplex detection of MI biomarkers CK-MB, troponin I and myoglobin, are 87.5% and 95.8%, respectively.
在这里,我们通过将之前的 V-Chip 与流体处理设计集成,开发了一种集成的体积柱状图芯片(IV-Chip)技术,生成了一种无仪器的即时检测设备,大大减少了检测时间和工作量。IV-Chip 测试仅需 1μL 从指尖采血分离的血清。使用移液器将血清样本和 ELISA 试剂直接加载到设备中,设备的两层移动会在微流道中产生均匀的液体段。在常规注射器产生的真空压力下,这些段依次流入 ELISA 孔,然后发生夹心 ELISA 反应。由于采用了自动洗涤和反应策略,IV-Chip 可快速检测心肌梗死生物标志物,检测时间大大缩短至 15 分钟。对心肌梗死生物标志物 CK-MB、肌钙蛋白 I 和肌红蛋白的定量多重检测的特异性和准确性分别为 87.5%和 95.8%。